biospecimen__admin__batch_number	384.50.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	68D309AB-15F5-49C3-A861-7A5740C9CF6A
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-ZS-A9CD-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-ZS-A9CD-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-ZS-A9CD-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104948
biospecimen__bio__day_of_creation	27
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	02
biospecimen__bio__pathology_report_file_name	TCGA-ZS-A9CD.11C6E09D-89C3-43B9-B884-247278242067.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A37G
biospecimen__bio__plate_row	D
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-ZS-A9CD
biospecimen__shared__patient_id	A9CD
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	98BB532B-F0CF-42E1-8C5B-A586BB3EADD4
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	36
clinical__chol_lihc_shared__albumin_result_specified_value	48
clinical__chol_lihc_shared__albumin_result_upper_limit	50
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	8
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	62
clinical__chol_lihc_shared__creatinine_upper_limit	106
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	73
clinical__chol_lihc_shared__fibrosis_ishak_score	5 - Nodular Formation and Incomplete Cirrhosis
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	11.7
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	17
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	73
clinical__clin_shared__day_of_form_completion	30
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__platelet_result_count	198
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2010
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	371
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__nte__residual_disease_post_new_tumor_event_margin_status	RX
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	3c08f647-9a07-4c2a-9be7-5c0bc3afd961
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-ZS-A9CD-01A-11R-A37G-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	9321088d-ab59-4e62-99c7-d4dd9326056d
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.91
gdc__analytes__analyte_id	cf3b18fb-24b0-4a4f-b911-39328ad69d8d
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	9197ca4c-e48c-43af-ba61-d894faf3cc24
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	f23ec093-178d-58d7-8ab2-523af687f18c
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1937
gdc__demographic__year_of_death	2013
gdc__diagnoses__age_at_diagnosis	26915
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26915.0
gdc__diagnoses__days_to_death	1386.0
gdc__diagnoses__diagnosis_id	83d5c6f2-dcb9-52a9-a26e-fce6d7606dc1
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__exposure_id	8e12f0ef-3410-566c-bdaa-4d3a14d22100
gdc__file_id	d98ec29f-0a0d-4509-9184-dee01d524b9b
gdc__file_name	2adb35ac-1ec2-45c9-837a-efc4eb7595be.mirbase21.mirnas.quantification.txt
gdc__file_size	50316
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	5154bae00fb8ff90a61f22a65a67d197
gdc__portions__is_ffpe	false
gdc__portions__portion_id	20e3dc26-6e73-41c2-8919-7944757ec642
gdc__portions__portion_number	11
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1268
gdc__samples__initial_weight	30.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	11C6E09D-89C3-43B9-B884-247278242067
gdc__samples__sample_id	e7570871-e848-416e-b84c-19c052a10a78
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	3.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	7147a689-bcdb-404a-99ea-a0e900e24c5b
gdc__submitter_id	mirna_swap_dr11_137_MirnaExpression9758ff2d-1586-4b36-a73d-4c4366009a5f_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	ZS
gdc__tissue_source_site__name	Tayside Tissue Bank
gdc__tissue_source_site__tissue_source_site_id	33a38997-77be-52dc-b79d-890d8d4b792b
gdc__treatments__treatment_id	283a3b0b-e2d6-5d1a-b72c-cd771b4601e5
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:55.929+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/3c08f647-9a07-4c2a-9be7-5c0bc3afd961-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/3c08f647-9a07-4c2a-9be7-5c0bc3afd961-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129687
manually_curated__local_md5	f14f2575e25fa2256e6b6d6478fe71ef
manually_curated__opengdc_download_date	2018-10-16T17:11:06.000527+02:00
manually_curated__opengdc_file_md5	add2b0314b5cb964e072f74513c25ffb
manually_curated__opengdc_file_size	50315
manually_curated__opengdc_id	3c08f647-9a07-4c2a-9be7-5c0bc3afd961-meq
manually_curated__origin_file_size	129687
manually_curated__origin_last_modified_date	Tue Oct 16 17:58:00 CEST 2018
manually_curated__origin_md5	f14f2575e25fa2256e6b6d6478fe71ef
manually_curated__tissue_status	tumoral
